Simmons Shaunna R, Lenhard Alexsandra P, Battaglia Michael C, Bou Ghanem Elsa N
Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA.
Vaccines (Basel). 2025 Apr 15;13(4):414. doi: 10.3390/vaccines13040414.
Neutrophils are essential for vaccine-mediated protection against pneumococcal infection and impairment in their antibacterial function contributes to reduced vaccine efficacy during aging. However, the signaling pathways that control the neutrophil responses in vaccinated hosts are not fully understood. The extracellular adenosine pathway is a known regulator of neutrophils in naïve hosts. The aim of this study was to test the role of this pathway in the function of neutrophils and their protection against infection upon vaccination as a function of the host's age. To test the role of adenosine in the antimicrobial activity of neutrophils against antibody-opsonized pneumococci, we used bone marrow-derived neutrophils isolated from wild-type or specific-adenosine-receptors knock-out mice. To measure the effect of adenosine receptor signaling in vivo, we treated vaccinated mice with agonists or antagonists that were specific to the different adenosine receptors prior to pulmonary challenge with pneumococci and assessed the bacterial burden and clinical score post-infection. We found that signaling via the adenosine 2B (A2BR) receptor but not the A2A or A1 receptors diminished the intracellular pneumococcal killing following antibody-mediated uptake in young hosts. In vivo, the agonism of the A2BR receptor significantly worsened the pneumococcal infection outcomes in young, vaccinated mice. In contrast, A2BR signaling had no effect on the intracellular bacterial killing by neutrophils from aged mice. Further, in vivo A2BR inhibition had no effect on the pneumococcal disease progression in aged, vaccinated mice. A2BR signaling reduced pneumococcal vaccine-mediated protection by impairing the antimicrobial activity of neutrophils against antibody-opsonized bacteria in young hosts. However, inhibiting this pathway was not sufficient to boost responses in aged hosts.
中性粒细胞对于疫苗介导的抗肺炎球菌感染保护至关重要,其抗菌功能受损会导致衰老过程中疫苗效力降低。然而,控制接种疫苗宿主中中性粒细胞反应的信号通路尚未完全明确。细胞外腺苷途径是未感染宿主中已知的中性粒细胞调节因子。本研究的目的是测试该途径在中性粒细胞功能及其作为宿主年龄函数的接种疫苗后抗感染保护中的作用。为了测试腺苷在中性粒细胞对抗体调理的肺炎球菌的抗菌活性中的作用,我们使用了从野生型或特定腺苷受体敲除小鼠分离的骨髓来源的中性粒细胞。为了测量腺苷受体信号在体内的作用,我们在用肺炎球菌进行肺部攻击之前,用对不同腺苷受体特异的激动剂或拮抗剂处理接种疫苗的小鼠,并评估感染后的细菌负荷和临床评分。我们发现,通过腺苷2B(A2BR)受体而非A2A或A1受体发出的信号减弱了年轻宿主中抗体介导摄取后细胞内肺炎球菌的杀伤。在体内,A2BR受体的激动显著恶化了年轻接种疫苗小鼠的肺炎球菌感染结果。相比之下,A2BR信号对老年小鼠中性粒细胞的细胞内细菌杀伤没有影响。此外,体内A2BR抑制对老年接种疫苗小鼠的肺炎球菌疾病进展没有影响。A2BR信号通过损害年轻宿主中中性粒细胞对抗体调理细菌的抗菌活性而降低了肺炎球菌疫苗介导的保护。然而,抑制该途径不足以增强老年宿主的反应。